Roth Capital Resumes Coverage on Halozyme Therapeutics (HALO) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. MRNA
3. EL
4. MRK
5. BILL
6. LOW
7. DE
8. RARE
9. TJX
10. LYTS

Go back to Roth Capital Resumes Coverage on Halozyme Therapeutics (HALO) at Buy
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 107.62 --0 (-0%)
Previous Close $107.62    52 Week High $18.39 
Open $107.62    52 Week Low $6.96 
Day High $107.62    P/E N/A 
Day Low $107.62    EPS $-0.58 
Volume 3,790